Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury

Neurosurgical Focus

Volumn 29, Issue 5, 2010, Pages 1-5

  Filippidis, Aristotelis S ^a   Papadopoulos, Dimitrios C ^b   Kapsalak, Eftychia Z ^c   Fountas, Kostas N ^a  

^a General Hospital of Larissa   (Greece)

^b GENERAL HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Biomarker; Children; Mild traumatic brain injury; S100B biomarker

Indexed keywords

BIOLOGICAL MARKER; NERVE GROWTH FACTOR; PROTEIN S 100;

ADOLESCENT; ADULT; AGE; AGED; BLOOD; BRAIN INJURY; CHILD; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; PRESCHOOL CHILD; REVIEW; UNITED STATES; UNNECESSARY PROCEDURE; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN INJURIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; S100 PROTEINS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES; UNNECESSARY PROCEDURES;

EID: 78649285366     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2010.8.FOCUS10185     Document Type: Article

References (27)

1. Akhtar JI, Spear RM, Senac MO, Peterson BM, Diaz SM: Detection of traumatic brain injury with magnetic resonance imaging and S-100B protein in children, despite normal computed tomography of the brain. Pediatr Crit Care Med 4: 322-326, 2003
2. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G: High serum S100B levels for trauma patients without head injuries. Neurosurgery 48:1255-1260, 2001
3. Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM: Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J Neurosurg 103 (1 Suppl):61-68, 2005
4. Castellani C, Bimbashi P, Ruttenstock E, Sacherer P, Stojakovic T, Weinberg AM: Neuroprotein S-100B-a useful parameter in paediatric patients with mild traumatic brain injury? Acta Paediatr 98:1607-1612, 2009
5. Castellani C, Stojakovic T, Cichocki M, Scharnagl H, Erwa W, Gutmann A, et al: Reference ranges for neuroprotein S-100B: from infants to adolescents. Clin Chem Lab Med 46:1296- 1299, 2008
6. Dash PK, Zhao J, Hergenroeder G, Moore AN: Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics 7:100-114, 2010
7. Gazzolo D, Michetti F, Bruschettini M, Marchese N, Lituania M, Mangraviti S, et al: Pediatric concentrations of S100B protein in blood: ageand sex-related changes. Clin Chem 49: 967-970, 2003
8. Geyer C, Ulrich A, Gräfe G, Stach B, Till H: Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. Clinical article. J Neurosurg Pediatr 4:339-344, 2009
9. Harpio R, Einarsson R: S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. Clin Biochem 37:512-518, 2004
10. Ingebrigtsen T, Romner B: Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. Restor Neurol Neurosci 21:171-176, 2003
11. Ingebrigtsen T, Romner B: Biochemical serum markers of traumatic brain injury. J Trauma 52:798-808, 2002
12. Jönsson H, Johnsson P, Höglund P, Alling C, Blomquist S: Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 14:698-701, 2000
13. Kövesdi E, Lückl J, Bukovics P, Farkas O, Pál J, Czeiter E, et al: Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir (Wien) 152:1-17, 2010
14. Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, Mc-Cunn M, Scalea T: Glial fibrillary acidic protein is highly correlated with brain injury. J Trauma 65:778-784, 2008
15. Moore BW: A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19:739-744, 1965
16. Morochovic R, Rácz O, Kitka M, Pingorová S, Cibur P, Tomková D, et al: Serum S100B protein in early management of patients after mild traumatic brain injury. Eur J Neurol 16:1112-1117, 2009
17. Pelinka LE, Harada N, Szalay L, Jafarmadar M, Redl H, Bahrami S: Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock 21: 72-76, 2004
18. Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H: GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 21:1553-1561, 2004
19. Petzold A, Keir G, Lim D, Smith M, Thompson EJ: Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull 61:281-285, 2003
20. Sandler SJI, Figaji AA, Adelson PD: Clinical applications of biomarkers in pediatric traumatic brain injury. Childs Nerv Syst 26:205-213, 2010
21. Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemelä O, Hillbom M: Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 56:1229- 1234, 2004
22. Undén J, Astrand R, Waterloo K, Ingebrigtsen T, Bellner J, Reinstrup P, et al: Clinical significance of serum S100B levels in neurointensive care. Neurocrit Care 6:94-99, 2007
23. Vos PE, Battistin L, Birbamer G, Gerstenbrand F, Potapov A, Prevec T, et al: EFNS guideline on mild traumatic brain injury: report of an EFNS task force. Eur J Neurol 9:207-219, 2002
24. Vos PE, Lamers KJB, Hendriks JCM, van Haaren M, Beems T, Zimmerman C, et al: Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 62:1303-1310, 2004
25. Wang DD, Bordey A: The astrocyte odyssey. Prog Neurobiol 86:342-367, 2008
26. Whitaker-Azmitia PM, Wingate M, Borella A, Gerlai R, Roder J, Azmitia EC: Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res 776: 51-60, 1997
27. Zimmer DB, Cornwall EH, Landar A, Song W: The S100 protein family: history, function, and expression. Brain Res Bull 37:417-429, 1995